Kevin Dromer

Senior Manager, GRA-CMC scientist

Brussels Metropolitan Area

About

Experience

  • UCB (13 yrs 9 mos)
    • Global Regulatory Affairs CMC & devices, Senior Manager
      Jun 2023 - Present · 3 yrs 1 mo

    • Group Leader
      Nov 2019 - May 2023 · 3 yrs 7 mos

    • Principal Scientist
      Apr 2017 - Nov 2019 · 2 yrs 8 mos

  • External Lecturer at Université du Maine
    Nov 2010 - Oct 2013 · 3 yrs

    External and full-time (one week per semester) lecturer in biochemistry/molecular biology for BSc students in their 2nd and 3rd year. Oversee about 40 students. Lectures cover a range of topics in molecular biology and biochemistry (genetics, enzymology, etc.) and are followed by laboratory training and examination.

  • Process Development Scientist at Lonza
    Apr 2010 - Oct 2012 · 2 yrs 7 mos

    Design and perform laboratory experiments to test the suitability and effectiveness of various chromatographic, filtration and other procedures for the purification of proteins, antibodies, ADCs, etc. for international customers. Oversee technology transfer and scale-up/down of processes to/from Pilot and Manufacturing. Ensure that equipment and materials required for a study are used as defined by cGMP and regulatory requirements. Regularly communicate by verbal presentations (meetings, teleconferences) and written reports to internal groups (Quality Assurance, Process Analytics, Quality Controls, Supply Chain, etc.), suppliers and customers.

  • Research Assistant at Fusion Antibodies Ltd
    Jan 2009 - Aug 2009 · 8 mos

    “Isolation, production and purification of Mycobacterium bovis antigens for the development of a multiplex chemiluminescent immunoassay for serological diagnosis of tuberculosis infection in cattle”. Enferplex TB assay® (www.enferscientific.com) launched in September 2009.

  • Research Assistant (internship) at INRA (National Institute of Agronomic Research, Nantes, France)
    Apr 2008 - Jul 2008 · 4 mos

    “Isolation, production and characteris(z)ation of wheat immunogenic proteins”. Techniques: PCR, cloning and subcloning, transformations and transfections, production (Yeast and E. Coli) in shake flasks and bioreactors (5/10L), purification and analysis. Reports writing, internal presentations.